LY3884961 + Sirolimus + Methylprednisolone

1 treatment and condition followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

LY3884961 + Sirolimus + Methylprednisolone
Treatment and conditionWhere it standsTrials
LY3884961 + Sirolimus + Methylprednisolone for parkinson diseasePhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1